203 related articles for article (PubMed ID: 18566102)
1. The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE-/- mice.
Schönberger T; Siegel-Axel D; Bussl R; Richter S; Judenhofer MS; Haubner R; Reischl G; Klingel K; Münch G; Seizer P; Pichler BJ; Gawaz M
Cardiovasc Res; 2008 Oct; 80(1):131-7. PubMed ID: 18566102
[TBL] [Abstract][Full Text] [Related]
2. Impact of glycoprotein VI and platelet adhesion on atherosclerosis--a possible role of fibronectin.
Bültmann A; Li Z; Wagner S; Peluso M; Schönberger T; Weis C; Konrad I; Stellos K; Massberg S; Nieswandt B; Gawaz M; Ungerer M; Münch G
J Mol Cell Cardiol; 2010 Sep; 49(3):532-42. PubMed ID: 20430036
[TBL] [Abstract][Full Text] [Related]
3. Imaging of injured and atherosclerotic arteries in mice using fluorescence-labeled glycoprotein VI-Fc.
Bigalke B; Pohlmeyer I; Schönberger T; Griessinger CM; Ungerer M; Botnar RM; Pichler BJ; Gawaz M
Eur J Radiol; 2011 Aug; 79(2):e63-9. PubMed ID: 21497471
[TBL] [Abstract][Full Text] [Related]
4. Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo.
Schulz C; Penz S; Hoffmann C; Langer H; Gillitzer A; Schneider S; Brandl R; Seidl S; Massberg S; Pichler B; Kremmer E; Stellos K; Schönberger T; Siess W; Gawaz M
Basic Res Cardiol; 2008 Jul; 103(4):356-67. PubMed ID: 18431526
[TBL] [Abstract][Full Text] [Related]
5. ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
Degen H; Borst O; Ziegler M; Mojica Munoz AK; Jamasbi J; Walker B; Göbel S; Fassbender J; Adler K; Brandl R; Münch G; Lorenz R; Siess W; Gawaz M; Ungerer M
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751543
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography/computed tomographic and magnetic resonance imaging in a murine model of progressive atherosclerosis using (64)Cu-labeled glycoprotein VI-Fc.
Bigalke B; Phinikaridou A; Andia ME; Cooper MS; Schuster A; Schönberger T; Griessinger CM; Wurster T; Onthank D; Ungerer M; Gawaz M; Nagel E; Botnar RM
Circ Cardiovasc Imaging; 2013 Nov; 6(6):957-64. PubMed ID: 24107491
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive imaging of glycoprotein VI binding to injured arterial lesions.
Gawaz M; Konrad I; Hauser AI; Sauer S; Li Z; Wester HJ; Bengel FM; Schwaiger M; Schömig A; Massberg S; Haubner R
Thromb Haemost; 2005 May; 93(5):910-3. PubMed ID: 15886808
[TBL] [Abstract][Full Text] [Related]
8. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.
Massberg S; Konrad I; Bültmann A; Schulz C; Münch G; Peluso M; Lorenz M; Schneider S; Besta F; Müller I; Hu B; Langer H; Kremmer E; Rudelius M; Heinzmann U; Ungerer M; Gawaz M
FASEB J; 2004 Feb; 18(2):397-9. PubMed ID: 14656994
[TBL] [Abstract][Full Text] [Related]
9. Vascular remodeling in ApoE-deficient mice: diet dependent modulation after carotid ligation.
Eschert H; Sindermann JR; Scheld HH; Breithardt G; Weissen-Plenz G
Atherosclerosis; 2009 May; 204(1):96-104. PubMed ID: 18848322
[TBL] [Abstract][Full Text] [Related]
10. Ex vivoimaging of injured arteries in rabbits using fluorescence-labelled glycoprotein VI-Fc.
Bigalke B; Lindemann S; Schönberger T; Pohlmeyer I; Chiribiri A; Schuster A; Botnar RM; Griessinger CM; Pichler BJ; Gawaz M
Platelets; 2012; 23(1):1-6. PubMed ID: 21671729
[TBL] [Abstract][Full Text] [Related]
11. Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice.
Selle J; Asare Y; Köhncke J; Alampour-Rajabi S; Shagdarsuren G; Klos A; Weber C; Jankowski J; Shagdarsuren E
Thromb Haemost; 2015 Oct; 114(4):848-58. PubMed ID: 26084965
[TBL] [Abstract][Full Text] [Related]
12. Local delivery of soluble platelet collagen receptor glycoprotein VI inhibits thrombus formation in vivo.
Bültmann A; Herdeg C; Li Z; Münch G; Baumgartner C; Langer H; Kremmer E; Geisler T; May A; Ungerer M; Gawaz M
Thromb Haemost; 2006 May; 95(5):763-6. PubMed ID: 16676064
[TBL] [Abstract][Full Text] [Related]
13. Deletion of junctional adhesion molecule A from platelets increases early-stage neointima formation after wire injury in hyperlipidemic mice.
Zhao Z; Vajen T; Karshovska E; Dickhout A; Schmitt MM; Megens RTA; von Hundelshausen P; Koeppel TA; Hackeng TM; Weber C; Koenen RR
J Cell Mol Med; 2017 Aug; 21(8):1523-1531. PubMed ID: 28211187
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of chlorinated and oxidized phospholipids in vascular tissue: implications for neointima formation.
Greig FH; Hutchison L; Spickett CM; Kennedy S
Clin Sci (Lond); 2015 May; 128(9):579-92. PubMed ID: 25524654
[TBL] [Abstract][Full Text] [Related]
15. Differential Inhibition of Human Atherosclerotic Plaque-Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies.
Jamasbi J; Megens RT; Bianchini M; Münch G; Ungerer M; Faussner A; Sherman S; Walker A; Goyal P; Jung S; Brandl R; Weber C; Lorenz R; Farndale R; Elia N; Siess W
J Am Coll Cardiol; 2015 Jun; 65(22):2404-15. PubMed ID: 26046734
[TBL] [Abstract][Full Text] [Related]
16. Platelet CD40 Mediates Leukocyte Recruitment and Neointima Formation after Arterial Denudation Injury in Atherosclerosis-Prone Mice.
Jin R; Xiao AY; Song Z; Yu S; Li J; Cui MZ; Li G
Am J Pathol; 2018 Jan; 188(1):252-263. PubMed ID: 29037856
[TBL] [Abstract][Full Text] [Related]
17. Dimeric Glycoprotein VI Binds to Collagen but Not to Fibrin.
Ebrahim M; Jamasbi J; Adler K; Megens RTA; M'Bengue Y; Blanchet X; Uhland K; Ungerer M; Brandl R; Weber C; Elia N; Lorenz R; Münch G; Siess W
Thromb Haemost; 2018 Feb; 118(2):351-361. PubMed ID: 29378359
[TBL] [Abstract][Full Text] [Related]
18. Relative antithrombotic effect of soluble GPVI dimer compared with anti-GPVI antibodies in mice.
Grüner S; Prostredna M; Koch M; Miura Y; Schulte V; Jung SM; Moroi M; Nieswandt B
Blood; 2005 Feb; 105(4):1492-9. PubMed ID: 15507524
[TBL] [Abstract][Full Text] [Related]
19. The Proteoglycan Biglycan Modulates Platelet Adhesion and Thrombus Formation in a GPVI-Dependent Manner.
Hoermann H; Krueger I; Maurus N; Reusswig F; Sun Y; Kohlmorgen C; Grandoch M; Fischer JW; Elvers M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830059
[TBL] [Abstract][Full Text] [Related]
20. Early hypercholesterolemia contributes to vasomotor dysfunction and injury associated atherogenesis that can be inhibited by nitric oxide.
Raman KG; Gandley RE; Rohland J; Zenati MS; Tzeng E
J Vasc Surg; 2011 Mar; 53(3):754-63. PubMed ID: 21163611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
